Purpose: To report the prevalence of the diabetic retinopathy in newly diagnosed patients with type II diabetes mellitus and to evaluate the association between the retinopathy and different clinical variables.
Method: A prospective study including all the newly diagnosed patients with type II diabetes mellitus between January 2001-March 2002 in the evidence of the Diabetes Center from Cluj has been conducted. The fundus appearance, age, sex, incidence of arterial hypertension and the diabetes therapy (diet alone, oral drugs, insulin) have been evaluated.
Results: During January 2001-March 2002, 487 patients have been diagnosed with type II diabetes mellitus in Cluj county. Diabetic retinopathy has been identified in 70 of these patients (14.37%). Most of the newly diagnosed patients with type II diabetes mellitus belonged to the age interval: 40-65 years, with an average of 58-59 years.
Conclusions: Among the 70 patients with diabetic retinopathy at the moment of type II diabetes diagnosis, the first place is occupied by the back-ground diabetic retinopathy. (11.70%), followed by the clinically significant macular edema (1.43%), proliferative diabetic retinopathy (1.02%) and preproliferative diabetic retinopathy (0.20%). Systolic and diastolic arterial hypertension has been associated with higher degrees of severity of the diabetic retinopathy.
Download full-text PDF |
Source |
---|
Pharmaceutics
January 2025
Centre for Public Health, Institute of Clinical Sciences, School of Medicine, Queen's University Belfast, Belfast BT7 1NN, UK.
Background/objectives: The visual acuity (VA) outcomes after the first and second years of anti-vascular endothelial growth factor (anti-VEGF) treatment in patients with diabetic macular oedema (DMO) were evaluated, and the factors associated with treatment success were investigated.
Methods: Using Medisoft electronic medical records (UK), this retrospective cohort study analysed VA outcomes, changes, and determinants in DMO patients at year 1 and year 2 after initial anti-VEGF injection. Descriptive analysis examined baseline demographics and clinical characteristics, while regression models were used to assess associations between these factors and changes in VA.
Nutrients
January 2025
Department of Botany and Genetics, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, 94901 Nitra, Slovakia.
Type 2 diabetes mellitus (T2DM), a serious metabolic disorder, is a worldwide health problem due to the alarming rise in prevalence and elevated morbidity and mortality. Chronic hyperglycemia, insulin resistance, and ineffective insulin effect and secretion are hallmarks of T2DM, leading to many serious secondary complications. These include, in particular, cardiovascular disorders, diabetic neuropathy, nephropathy and retinopathy, diabetic foot, osteoporosis, liver damage, susceptibility to infections and some cancers.
View Article and Find Full Text PDFMedicina (Kaunas)
January 2025
Department of Ophthalmology, Medical Academy, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, Lithuania.
: Diabetic retinopathy (DR) is a common diabetes complication and a leading cause of blindness. Although bariatric surgery (BS) is well studied for diabetes management, its effects on DR onset and progression, particularly long-term outcomes, remain underexplored. This review seeks to evaluate the short- and long-term retinal outcomes of BS in diabetic patients.
View Article and Find Full Text PDFMedicina (Kaunas)
January 2025
2nd Department of Ophthalmology, Attikon Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
The neutrophil to lymphocyte ratio (NLR) and other full blood count indices have been used as a marker of inflammation in a variety of diseases. The aim of the current review is to summarize the existing knowledge on the use of these indices in retinal diseases. A systematic review of the literature was conducted to find eligible articles.
View Article and Find Full Text PDFMedicina (Kaunas)
December 2024
Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, CNRS UMR 5305, 69367 Lyon, France.
: According to the International Working Group on Diabetic Foot (IWGDF) risk classification, the estimated risk of developing a diabetic foot ulcer (DFU) is much higher in patients with a history of DFUs (Grade 3) compared to those with a peripheral neuropathy but without a history of DFUs (Grades 1 and 2). It has been suggested that microcirculation impairment is involved in DFU genesis and could be taken into account to refine the existing risk classification. The aim of this study was to evaluate microcirculation parameters in patients with diabetes according to their estimated DFU risk.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!